BREATH TEST FOR DISEASE DETECTION

COVID-19

Breathonix breath test solution provides 60 seconds detection with over 90% accuracy based on Initial clinical trials with National Centre for Infectious Diseases (NCID) of Singapore.

Other Fatal Diseases

Ongoing clinical trials to detect a wide range of diseases including early detection of Lung Cancer, Nasopharyngeal Cancer and Tuberculosis. 

KEY HIGHLIGHTS

Slingshot 2019 MedTech Winner

Breathonix was the MedTech Sector Winner (out of 2400 startups) of Slingshot 2019 competition.

6+ Years of Breath Analysis Research

The technology is developed from 6+ years of breath analysis research in National University of Singapore (NUS).

Backed by Reputable Investors

Funded by NUS Enterprise, Origgin and Antler.

COLLABORATION

To the ones who made it possible 

JOIN OUR MISSION

Reimagine Diagnostics with Rapid Breath Test for Disease Detection

LATEST UPDATES

Mohammad Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Health Authority (DHA) and Breathonix Pte Ltd are jointly carrying out a trial to assess the accuracy of an easy-to-use breath test to detect COVID-19 within one minute.
These superheroes are as real as they get. They are, in fact, scientists, doctors and clinicians continuously tinkering in tech labs across Singapore. Meet the individuals facing off against some of the world's most pressing health issues -- from cancer to heart disease and diabetic retinopathy, as they harness the incredible power of Artificial Intelligence. The Hidden Layer: Healthcare Trailblazers
About On The Red Dot: CNA's weekly programme documents the stories of ordinary Singaporeans and celebrates their resilience, identity and sense of belonging.